47781-317 : Nevirapine Extended Release 400 mg Oral Tablet
NDC: | 47781-317 |
Labeler: | Alvogen Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Nevirapine Extended Release |
Dosage Form: | Oral Tablet |
Application #: | ANDA204621 |
Rev. Date: |
Appearance:
Markings: | ALV317 |
Shapes: |
Capsule |
Colors: |
White |
Size (mm): | 19 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 47781-317-30: 30 TABLET IN 1 BOTTLE (47781‑317‑30)
Active Ingredients:
- Nevirapine
Dosage Strength:
- 400 mg
Inactive Ingredients:
- Lactose Monohydrate
- Hypromelloses
- Zinc Stearate
Pharmaceutical Classes:
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Non-Nucleoside Analog [EXT]
- Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- Cytochrome P450 3A Inducers [MoA]
- Cytochrome P450 2B6 Inducers [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 47781-308Next: 47781-331 >
Related Discussions:
ILVITRIMl / Nevirapine
Hi after six weeks checkup my daughter tested negative, before she was using Nevirapine. Now they gave her the ilvitrim ... 3 replies
Hi after six weeks checkup my daughter tested negative, before she was using Nevirapine. Now they gave her the ilvitrim ... 3 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.